In the News
-
Apr 10, 2016
Letter to the Editor: Kudos to Buddy Carter from Medicare patients
Savannah Morning News
On behalf of Medicare patients in Georgia who rely on long term care (LTC) pharmacies for their prescription medication, I’d like to thank Congressman Buddy Carter, R-Ga., for advocating for increased transparency and fairness in prescription drug pricing…Read More -
Mar 17, 2016
Secretive Pharmacy Benefit Manager Pricing Schemes Face Growing, Bipartisan Capitol Hill Scrutiny
Morning Consult
When the notorious former Turing Pharmaceuticals CEO, Martin Shkreli, made a recent appearance on Capitol Hill to “invoke [his] fifth amendment rights” at a House Oversight and Government Reform Committee hearing on prescription drug pricing abuses, focus on his alleged misdeeds served a useful purpose: he put a face on the need for more competition and pricing transparency in America’s increasingly complex and tumultuous pharmaceutical marketplace…Read More -
Mar 11, 2016
LTC exempted from newly-passed drug bill’s ‘lock-in’ provision
McKnight’s
A bill passed by the Senate on Thursday is earning praise from a leading long-term care pharmacy group for exempting nursing homes from its controversial “lock-in” provision that limits Medicare beneficiaries to using one pharmacy…Read More -
Feb 2, 2016
MAC Prices Hit LTC Sites Hard: Margin Loss Seen
Specialty Pharmacy Continuum
Robert Warnock, PharmD, realized that he had a problem. The senior vice president of pharmacy services for PruittHealth, Dr. Warnock oversees pharmacy services for five long-term care (LTC) pharmacies affiliated with Pruitt, which operates about 100 skilled care nursing facilities in the Southeast…Read More -
Nov 24, 2015
PBMs Scrutinized for LTC Pharmacy Payment Practices
Pharmacy Times
Long-term care (LTC) pharmacies’ current prescription drug reimbursement model may not be sustainable, a new analysis suggests…Read More -
Nov 20, 2015
Community, Long-Term Care Pharmacists Seek More Transparency From PBMs
Inside Health Policy
Community and long-term care pharmacists are pressing for more transparency in pharmacy benefit managers’ Maximum Allowable Cost lists that determine how much pharmacies are paid for generic drugs, pushing back against PBMs’ claims that transparency could lead to higher drug prices…Read More -
Oct 9, 2015
Value-based payment, consolidation threaten LTC pharmacies, report claims
McKnight’s
The shift to value based payment models, drug repackaging restrictions and consolidations are among the biggest concerns for the long-term care pharmacy sector, according to report released Thursday by research firm Avalere Health and the Senior Care Pharmacy Coalition…Read More -
Oct 8, 2015
Long Term Care Pharmacy Sector Plays Key, Growing Role in US Seniors’ Care as New Payment, Delivery Models Gain Prevalence
Pharmacy Times
A new Avalere Health study of the nation’s growing long term care (LTC) pharmacy sector – the most detailed analysis since Medicare Part D was implemented in 2006 – finds LTC pharmacies playing a greater role in seniors’ clinical care as new health payment and delivery models such as Accountable Care Organizations (ACOs), bundled payments and value-based purchasing proliferate amid a rapidly changing healthcare marketplace…Read More -
Sep 2, 2015
State Efforts to Reform Secretive Pharmacy Benefit Manager (PBM) Pricing Policies Gain National Momentum
Roll Call
Americans today rightly demand more transparency in their governmental, financial and educational institutions. It is the foundation upon which to assess accountability, performance and trust…Read More
View Archives
By Date
- October 2025 (1)
- September 2025 (5)
- August 2025 (4)
- July 2025 (1)
- June 2025 (2)
- May 2025 (4)
- April 2025 (2)
- March 2025 (3)
- February 2025 (2)
- January 2025 (2)
- December 2024 (3)
- August 2024 (2)
- July 2024 (3)
- June 2024 (2)